Complications in Patients Undergoing Laparoscopic Bariatric Surgery in an ERABS-optimized, High-Volume, Single Center During 2020 and 2021
- PMID: 37199830
- PMCID: PMC10289944
- DOI: 10.1007/s11695-023-06596-1
Complications in Patients Undergoing Laparoscopic Bariatric Surgery in an ERABS-optimized, High-Volume, Single Center During 2020 and 2021
Abstract
Purpose: Complication rates after fast-track optimization in bariatric surgery are varying. The aim of this study was to identify short-term complications in patients undergoing laparoscopic sleeve gastrectomy (SG) in an ERABS (enhanced recovery after bariatric surgery) optimized setup.
Materials and methods: This study is an observational analysis of a consecutive cohort of 1600 patients undergoing SG at an ERABS-optimized, private hospital during 2020 and 2021. Primary outcomes were length of stay, mortality, readmissions, reoperations, and complications according to the Clavien-Dindo classification (CDC) within postoperative day (POD) 30 and 90. Secondary outcomes were weight loss and quality of life (QoL) according to Moorehead-Ardelt questionnaires during the first postoperative year.
Results: Primary outcomes: 99.1% of patients were discharged within POD 1. The 90-day mortality rate was zero. There were 1% readmissions and 1.2% reoperations within POD 30. Total 30-day complication rate was 4.6%, where 3.4% accounted for CDC grades ≤ II, and 1.3% accounted for CDC grade III. There were zero grade IV-V complications.
Secondary outcomes: One year after surgery, weight loss was substantial (p < 0.001), with an excess weight loss of 71.9%, and QoL had significantly increased (p < 0.001).
Conclusion: This study demonstrates that the use of an ERABS protocol in bariatric surgery does not compromise neither safety nor efficacy. Complication rates were low, and weight loss was significant. This study thus provides strong arguments that ERABS programs are beneficial in bariatric surgery.
Keywords: Bariatric surgery; Clavien-Dindo classification; ERABS; ERAS; Fast-track surgery; Sleeve gastrectomy.
© 2023. The Author(s).
Conflict of interest statement
Katrine Stryhn, Lærke Alstrup, Claus Riber, Michael Ørting, Rakin Hadad, Jan Hvistendahl, Carsten Tollund, Niels Boye, and Steen B. Haugaard declare no conflict of interest. Peter Funch-Jensen declares potential conflicts of interest, as he has received research grants from Medtronic, Johnson&Johnson, and AstraZeneca, and holds shares in Novo Nordisk A/S.
Similar articles
-
Reducing complication rates and hospital readmissions while revising the enhanced recovery after bariatric surgery (ERABS) protocol.Surg Endosc. 2021 Feb;35(2):612-619. doi: 10.1007/s00464-020-07422-w. Epub 2020 Feb 12. Surg Endosc. 2021. PMID: 32052150
-
Enhanced recovery after bariatric surgery (ERABS) protocol implementation in a laparoscopic center.Minim Invasive Ther Allied Technol. 2022 Feb;31(2):269-275. doi: 10.1080/13645706.2020.1796708. Epub 2020 Jul 27. Minim Invasive Ther Allied Technol. 2022. PMID: 32716664
-
The Interest of Enhanced Recovery After Surgery in a New Bariatric Center.J Laparoendosc Adv Surg Tech A. 2020 Jan;30(1):6-11. doi: 10.1089/lap.2019.0456. Epub 2019 Oct 1. J Laparoendosc Adv Surg Tech A. 2020. PMID: 31573396
-
Laparoscopic Greater Curvature Plication and Laparoscopic Sleeve Gastrectomy Treatments for Obesity: Systematic Review and Meta-Analysis of Short- and Mid-Term Results.Obes Surg. 2018 Oct;28(10):3199-3212. doi: 10.1007/s11695-018-3330-9. Obes Surg. 2018. PMID: 29951784
-
Sleeve Gastrectomy: Surgical Tips.J Laparoendosc Adv Surg Tech A. 2018 Aug;28(8):930-937. doi: 10.1089/lap.2018.0392. Epub 2018 Jul 13. J Laparoendosc Adv Surg Tech A. 2018. PMID: 30004814 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical